ArticleInflammation research : official journal of the European Histamine Research Society ... [et al.]2026
Endothelial cell-specific knockout of ATG5 ameliorates inflammation and renal fibrosis by regulating pyroptosis.
Article in Inflammation research : official journal of the European Histamine Research Society ... [et al.], 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
Abstract
objectivesATG5, a key regulator of autophagy-associated inflammation, is markedly upregulated under inflammatory conditions. In this study, we observed significantly elevated ATG5 expression in the kidneys of patients with renal fibrosis and in mouse kidneys after unilateral ureteral obstruction (UUO), particularly in renal tubules and glomeruli. Recent studies suggest that enhanced ATG5-mediated autophagy in tubular epithelial cells targets the NF-κB pathway to alleviate renal injury. The glomerulus is a dense capillary network primarily composed of endothelial cells, which represent a key immune cell population in the kidney. However, whether endothelial ATG5 exerts a function similar to that of tubular ATG5 during the progression of renal fibrosis remains unclear.
methodsFirst, Sirius red staining, immunohistochemistry staining and other and pathological methods were used to analyze the expression of ATG5 in relation to the progression of renal fibrosis in patients and UUO model mice. We next observed the effects of endothelial-specific knockout of ATG5 in mice with renal fibrosis induced by the UUO model by ultrasound image assessment, HE staining, and Masson staining. Human umbilical vein endothelial cells (HUVECs) were isolated, and their regulation of inflammation and promotion of renal fibrosis were analyzed by overexpression and knockdown of ATG5 using in vitro synthetic mRNA and siRNA interference techniques. Transmission electron microscopy (TEM), qPCR and Western blotting were used to determine the effect of endothelial ATG5 on promoting inflammation-dependent pyroptosis in vitro and in vivo. Finally, the expression of GSDMD, a key pyroptosis gene, was examined in the kidneys of clinical renal fiber patients by immunohistochemistry staining.
resultsWe successfully generated endothelial-specific ATG5 knockout (Tek-Cre ATG5 KO) mice and found that endothelial cell deletion of ATG5 attenuated UUO-induced renal fibrosis. Mechanistically, endothelial-specific ATG5 knockout suppressed pyroptosis and the release of inflammatory factors in the UUO model, primarily by inhibiting GSDMD expression and its cleavage into the N-GSDMD fragment during canonical NLRP3 inflammasome activation. Electron microscopy results showed that ATG5 mainly caused pyroptosis independent of plasma membrane pores in endothelial cells. Conditioned medium from human umbilical vein endothelial cells with ATG5 knockdown inhibited the expression of the key fibrotic marker TGF-β1 in renal tubular epithelial HK-2 cells. Consistent results were obtained when HK-2 cells were cocultured with serum from UUO mice with endothelial-specific ATG5 knockout. Furthermore, GSDMD expression was positively correlated with the degree of fibrosis in patients with renal fibrosis.
conclusionsCollectively, our findings demonstrate that ATG5 modulates the inflammatory response by mediating pyroptosis and exacerbates UUO-induced renal fibrosis in endothelial cells, which is in striking contrast to its role in renal tubular epithelial cells. These results highlight the cell-type-specific functions of ATG5 during renal fibrogenesis. Furthermore, our study provides a novel theoretical basis for the development of targeted therapeutic strategies against renal fibrosis in clinical practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.